THERIFLASH
DEAD

Serial Number

76220858

Owner

Therics, Inc.

Attorney

Paul J. Reilly

Filing Date

Mar 5, 2001

Add to watchlist:

No watchlists yet
View on USPTO

THERIFLASH Trademark

Serial Number: 76220858

THERIFLASH is a trademark filed by Therics, Inc. on March 5, 2001. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 40 (Treatment & Processing), Class 30 (Staple Foods). The application is currently no longer active.

Owner Contact Info

Therics, Inc. (27 trademarks)

99 Hudson Street
New York, NY 100132815

Entity Type: 03

Trademark Details

Filing Date

March 5, 2001

Registration Date

Not Registered

Published for Opposition

September 23, 2003

Goods & Services

Candy, chocolate coated candy, mints

Manufacture of pharmaceuticals, implants, tissue growth matrices, scaffolds, three dimensional biological models, oral and transdermal drug devices to the order and specification of others; manufacture of general product lines in the fields of pharmaceuticals, orthopedic, dentistry, transplants, biomedical research and medicine to the order and specification of others

Dissolving pills, tablets and lozenges delivered by mouth for the treatment of various diseases and conditions in humans or animals, namely, asthma, chronic obstructive pulmomary disease (CORD) and other diseases of the pulmonary system; hypertension, atherosclerosis, arrythmias, coagulation disorders, congestive heart failure and other diseases of the circulatory system, namely, the management of lipids and other risk factors; wound healing and closure, antiadhesion, and other treatment secondary to surgical procedures or diseases of the soft tissue; infectious diseases; tissue and organ transplantation; bone grafting, bone augmentation, fracture repair and other conditions of the muscoloskeletal system; cancer; mental disorders, epilepsy, Parkinson, attention deficit disorder, Alzheimer and other diseases of the central nervous system; gastrointestinal disorders; pain, localized and neuropathic; diabetes, thyroid disorders and other disorders of the endocrine system; infertility, endometriosis and other conditions of the female reproductive system; impotence and other disorders of the male reproductive system; lupus, and other disorders of the immune system; smoking cessation and other behavioral modification treatments; vitamin and other nutrient deficiencies; allergies; nausea; amyotrophic lateral sclerosis; dissolving gelatin capsules sold empty for pharmaceuticals; transdermal patches comprised of organic or synthetic materials for the timed release of pharmaceuticals or medicines

Drug delivery implants

Filing History

EXPARTE APPEAL TERMINATED
Aug 24, 2004 EXPT
ABANDONMENT - NO USE STATEMENT FILED
Aug 16, 2004 ABN6
CASE FILE IN TICRS
Jun 9, 2004 CFIT
NOA MAILED - SOU REQUIRED FROM APPLICANT
Dec 16, 2003 NOAM
PUBLISHED FOR OPPOSITION
Sep 23, 2003 PUBO
NOTICE OF PUBLICATION
Sep 3, 2003 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 30, 2003 CNSA
EXAMINERS AMENDMENT MAILED
Jun 25, 2003 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jun 18, 2003 ZZZX
APPROVED FOR PUB - PRINCIPAL REGISTER
May 6, 2003 CNSA
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Mar 17, 2003 JURT
EX PARTE APPEAL-INSTITUTED
Mar 17, 2003 EXPI
EXPARTE APPEAL RECEIVED AT TTAB
Mar 5, 2003 EXAF
PAPER RECEIVED
Feb 25, 2003 MAIL
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 21, 2003 CRFA
FINAL REFUSAL MAILED
Aug 21, 2002 CNFR
REINSTATED
Aug 1, 2002 REIN
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 6, 2002 CRFA
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Apr 8, 2002 ABN2
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 17, 2002 CRFA
NON-FINAL ACTION MAILED
Jul 17, 2001 CNRT
ASSIGNED TO EXAMINER
Jul 3, 2001 DOCK
ASSIGNED TO EXAMINER
Jun 28, 2001 DOCK